Stay updated on Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page
- Check5 days agoChange DetectedNo additions or deletions were detected on the Study Details page, and the page content remains focused on the study details.SummaryDifference0.5%

- Check12 days agoNo Change Detected
- Check34 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check41 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check55 days agoChange DetectedUpdate page revision from v3.0.1 to v3.0.2; remove the old 'Revision: v3.0.1' line and the 'Back to Top' element.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check70 days agoChange DetectedThe web page has updated the facility name and location details, specifically changing from 'Saint Louis, Missouri' to 'St Louis, Missouri'. Additionally, the drug 'sitravatinib' has been added, indicating a potential update in treatment options.SummaryDifference1%

Stay in the know with updates to Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page.